ROLECA Trademark
Serial Number: 79343685 • Registration: 7123498
ROLECA is a trademark filed by
Medicocensus GmbH
on February 24, 2022. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Robert S. Broder Collard & Roe, P.C.
1077 Northern Blvd.
Roslyn
NY 11576
UNITED STATES
Trademark Details
Filing Date
February 24, 2022
Registration Date
August 1, 2023
Published for Opposition
May 16, 2023
Filing History
NEW REPRESENTATIVE AT IB RECEIVED
Apr 27, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 27, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 2, 2023 FICS
FINAL DISPOSITION PROCESSED
Nov 1, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 1, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 1, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 1, 2023 R.PR
NOTIFICATION PROCESSED BY IB
May 17, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 16, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 16, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 26, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 26, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 26, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 10, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 5, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 5, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 5, 2023 TROA
REFUSAL PROCESSED BY IB
Feb 28, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 3, 2023 RFCS
REFUSAL PROCESSED BY MPU
Feb 3, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 9, 2022 RFCR
NON-FINAL ACTION WRITTEN
Dec 8, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 8, 2022 DOCK
CHANGE OF OWNER RECEIVED FROM IB
Oct 14, 2022 CHLD
APPLICATION FILING RECEIPT MAILED
Jul 5, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 1, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 30, 2022 REPR
